Prevalence of dyslipidaemia in statin-treated patients in Ireland: Irish results of the DYSlipidaemia International Study (DYSIS)

By Horgan S.  

Irish Journal of Medical Science, Vol. 180, Iss. 2, 2011-06 ,pp. : 343-349

Springer Publishing Company

Access to resources Recommend Favorite

Determinants of CRP level in statin-treated patients

By Liem A. H.   van de Woestijne A. P.   Zwinderman A. H.   Visseren F. L. J.   Jukema J. W.  

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 1065-1068

Informa Healthcare

Access to resources Recommend Favorite

ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patients

By Liem A. H.   van de Woestijne A. P.   Roeters van Lennep H. W. O.   Zwinderman A. H.   van der Steeg W. A.   Jukema J. W.  

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 359-364

Informa Healthcare

Access to resources Recommend Favorite

Icosabutate, a Structurally Engineered Fatty Acid, Improves the Cardiovascular Risk Profile in Statin-Treated Patients with Residual Hypertriglyceridemia

By  

Cardiology, Vol. 135, Iss. 1, 2016-05 ,pp. : 3-12

Karger

Access to resources Recommend Favorite

Safety and tolerability of prolonged-release nicotinic acid in statin-treated patients

By Birjmohun R. S.   Kastelein J. J. P.   Poldermans D.   Stroes E. S. G   Hostalek U.   Assmann G.  

Current Medical Research and Opinion, Vol. 23, Iss. 7, 2007-07 ,pp. : 1707-1713

Informa Healthcare

Access to resources Recommend Favorite